327 related articles for article (PubMed ID: 18434302)
1. Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11.
He KL; Deora AB; Xiong H; Ling Q; Weksler BB; Niesvizky R; Hajjar KA
J Biol Chem; 2008 Jul; 283(28):19192-200. PubMed ID: 18434302
[TBL] [Abstract][Full Text] [Related]
2. The endothelial cell annexin A2 system and vascular fibrinolysis.
Dassah M; Deora AB; He K; Hajjar KA
Gen Physiol Biophys; 2009; 28 Spec No Focus(SPEC):F20-8. PubMed ID: 20093722
[TBL] [Abstract][Full Text] [Related]
3. The annexin A2 system and vascular homeostasis.
Flood EC; Hajjar KA
Vascul Pharmacol; 2011; 54(3-6):59-67. PubMed ID: 21440088
[TBL] [Abstract][Full Text] [Related]
4. Regulation of fibrinolysis by S100A10 in vivo.
Surette AP; Madureira PA; Phipps KD; Miller VA; Svenningsson P; Waisman DM
Blood; 2011 Sep; 118(11):3172-81. PubMed ID: 21768297
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of plasmin generation by S100A10.
Miller VA; Madureira PA; Kamaludin AA; Komar J; Sharma V; Sahni G; Thelwell C; Longstaff C; Waisman DM
Thromb Haemost; 2017 Jun; 117(6):1058-1071. PubMed ID: 28382372
[TBL] [Abstract][Full Text] [Related]
6. Feedback regulation of endothelial cell surface plasmin generation by PKC-dependent phosphorylation of annexin A2.
He KL; Sui G; Xiong H; Broekman MJ; Huang B; Marcus AJ; Hajjar KA
J Biol Chem; 2011 Apr; 286(17):15428-39. PubMed ID: 21115493
[TBL] [Abstract][Full Text] [Related]
7. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.
Kwon M; MacLeod TJ; Zhang Y; Waisman DM
Front Biosci; 2005 Jan; 10():300-25. PubMed ID: 15574370
[TBL] [Abstract][Full Text] [Related]
8. Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin.
MacLeod TJ; Kwon M; Filipenko NR; Waisman DM
J Biol Chem; 2003 Jul; 278(28):25577-84. PubMed ID: 12730231
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cell surface protease receptor S100A10 by retinoic acid therapy in acute promyelocytic leukemia (APL)
Holloway RW; Thomas ML; Cohen AM; Bharadwaj AG; Rahman M; Marcato P; Marignani PA; Waisman DM
Cell Death Dis; 2018 Sep; 9(9):920. PubMed ID: 30206209
[TBL] [Abstract][Full Text] [Related]
10. An annexin 2 phosphorylation switch mediates p11-dependent translocation of annexin 2 to the cell surface.
Deora AB; Kreitzer G; Jacovina AT; Hajjar KA
J Biol Chem; 2004 Oct; 279(42):43411-8. PubMed ID: 15302870
[TBL] [Abstract][Full Text] [Related]
11. Annexin A2-S100A10 heterotetramer is upregulated by PML/RARα fusion protein and promotes plasminogen-dependent fibrinolysis and matrix invasion in acute promyelocytic leukemia.
Huang D; Yang Y; Sun J; Dong X; Wang J; Liu H; Lu C; Chen X; Shao J; Yan J
Front Med; 2017 Sep; 11(3):410-422. PubMed ID: 28687976
[TBL] [Abstract][Full Text] [Related]
12. The Annexin A2/S100A10 Complex: The Mutualistic Symbiosis of Two Distinct Proteins.
Bharadwaj A; Kempster E; Waisman DM
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944495
[TBL] [Abstract][Full Text] [Related]
13. Thrombin induces endothelial cell-surface exposure of the plasminogen receptor annexin 2.
Peterson EA; Sutherland MR; Nesheim ME; Pryzdial EL
J Cell Sci; 2003 Jun; 116(Pt 12):2399-408. PubMed ID: 12724354
[TBL] [Abstract][Full Text] [Related]
14. The role of the annexin A2 heterotetramer in vascular fibrinolysis.
Madureira PA; Surette AP; Phipps KD; Taboski MA; Miller VA; Waisman DM
Blood; 2011 Nov; 118(18):4789-97. PubMed ID: 21908427
[TBL] [Abstract][Full Text] [Related]
15. Annexin A2 system in human biology: cell surface and beyond.
Luo M; Hajjar KA
Semin Thromb Hemost; 2013 Jun; 39(4):338-46. PubMed ID: 23483454
[TBL] [Abstract][Full Text] [Related]
16. The annexin A2/S100A10 system in health and disease: emerging paradigms.
Hedhli N; Falcone DJ; Huang B; Cesarman-Maus G; Kraemer R; Zhai H; Tsirka SE; Santambrogio L; Hajjar KA
J Biomed Biotechnol; 2012; 2012():406273. PubMed ID: 23193360
[TBL] [Abstract][Full Text] [Related]
17. Regulation of S100A10 by the PML-RAR-α oncoprotein.
O'Connell PA; Madureira PA; Berman JN; Liwski RS; Waisman DM
Blood; 2011 Apr; 117(15):4095-105. PubMed ID: 21310922
[TBL] [Abstract][Full Text] [Related]
18. Ceramide 1-phosphate mediates endothelial cell invasion via the annexin a2-p11 heterotetrameric protein complex.
Hankins JL; Ward KE; Linton SS; Barth BM; Stahelin RV; Fox TE; Kester M
J Biol Chem; 2013 Jul; 288(27):19726-38. PubMed ID: 23696646
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions.
Lobov S; Croucher DR; Saunders DN; Ranson M
Thromb Haemost; 2008 Aug; 100(2):319-29. PubMed ID: 18690354
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Ion Channels and Receptors by p11 (S100A10).
Seo JS; Svenningsson P
Trends Pharmacol Sci; 2020 Jul; 41(7):487-497. PubMed ID: 32418644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
